skip to main content

Funding Opportunities

Newly Posted Opportunities:

Submit by December 17, 2018 to the St. Baldrick’s Foundation

Limited Submission

    Title: Summer Fellows 2019
    Award: $5,000
    Link: https://umms.infoready4.com/#competitionDetail/1780520
    St. Baldrick’s offers Summer Fellowship Awards, funding stipends for students to work in a pediatric oncology setting for a summer. The total award, paid to the institution, is $5,000. Applicants must be institutionally-nominated.

Submit by January 7, 2019 to the St. Baldrick’s Foundation

Limited Submission

    Title: Spring Grant Cycle 2019
    Award: up to $2,500,000, category-dependent
    Link: https://umms.infoready4.com/#competitionDetail/1780506
    Spring cycle grants are funded based on scientific review. The following categories are available in the Spring Cycle: St. Baldrick’s Scholars, St. Baldrick’s International Scholars, Consortium Research Grants, Research Grants, Supportive Care Research Grants

Submit by January 7, 2019 to the National Comprehensive Cancer Network

    Title: Phase I/II Clinical Trials and Correlative Trials of trifluridine/tipiracil for Gastrointestinal and other Solid Tumors
    Award: up to $500,000
    Link: https://www.nccn.org/clinical_trials/investigators/default.asp
    NCCN has received a research grant from Taiho Oncology, Inc. to support the performance of clinical and correlative studies of trifluridine/tipiracil (FTD/TPI), in the treatment of gastrointestinal (GI) malignancies and other solid tumors. NCCN will serve as the funding organization. Grants are available only to investigators from NCCN Member Institutions.

Submit by January 15, 2019 to the University of Michigan Center for the Assessment of the Public Health Impact of Tobacco Regulations

    Title: Pilot Project in Tobacco Regulatory Science
    Award: $20,000-$40,000
    Link: https://drive.google.com/file/d/1TphCpWSfidorE09PWcTfcWx9ydsSVLR5/
    This RFA supports pilot tobacco regulatory science research activities that inform the execution of the Family Smoking Prevention and Tobacco Control Act (TCA). The priority research areas include biological, behavioral, social and economic analyses of modified risk tobacco products (e.g., e-cigarettes, IQOS, etc.), nicotine reduction and flavored products. Other areas of interest include disparities research on tobacco use and consequences, marketing and advertising of tobacco products, and tobacco use in youth and young adults.

Submit by January 16, 2019 to the American Association for Cancer Research (AACR), Debbie's Dream Foundation

    Title: Gastric Cancer Research Fellowships
    Award: $50,000
    Link: https://www.aacr.org/Funding/Pages/Funding-Detail.aspx?ItemID=15
    A joint effort to encourage and support postdoctoral or clinical research fellows to conduct gastric cancer research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to gastric cancer.

Rogel Cancer Funds (submit monthly):

    Title: Research Grant
    Amount: $75,000

    Title: Idea Grant
    Amount: $40,000

    Title: FIRST & GOAL Resubmission Support
    Amount: $100,000

Contact: Kristin Van Raaphorst kvanraap@med.umich.edu

Recently Announced

Submit by December 17, 2018 to the Gray Foundation

    Title: Basser Initiative Team Science Grant Foundation
    Award: $3,000,000 - 5,000,000
    Link: https://www.grayfoundation.org/team-science/
    LOI due 12/17; full application (by invitation) due 3/1. The Gray Foundation is searching for highly meritorious research projects that bring together the best minds in cancer research to develop new therapies, prevention approaches, and better understanding of the fundamental mechanisms at play in BRCA-related cancers. Funding will be for a period of 3-5 years.

Submit by January 15, 2019 to SWOG / Hope Foundation

    Title: Impact Award 2019
    Award: $250,000
    Link: : https://thehopefoundation.org/research-funding/juried-programs/swog-hope-foundation-impact-award/
    Encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects. The work proposed should use resources from completed SWOG trials or be directly translatable to clinical trials in SWOG and the NCTN in the foreseeable future. Funding for smaller feasibility projects that are critical to the conduct of future SWOG trials are also encouraged.

Submit by January 17, 2019 to American Association for Cancer Research-AstraZeneca Ovarian Cancer Research Fellowship

    Title: Ovarian Cancer Research Fellowships
    Award: $120,000
    Link: https://www.aacr.org/Funding/Pages/Funding-Detail.aspx?ItemID=58
    The research proposed for funding must have direct applicability to ovarian cancer with a specific focus on DNA damage repair pathways and may be basic, translational, clinical, or epidemiological in nature. Any proposals that address topics unrelated to DNA damage repair pathways in ovarian cancer will NOT be accepted.

Submit by January 24, 2019 to National Institutes of Health (NIH)

    Title: Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)
    Award: $800,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-012.html
    Participating Institutes and Centers will support educational activities that develop cross-cutting methodologies and analytics that are needed to more rapidly advance behavioral and social sciences research (BSSR) and are not already well addressed by existing educational programs widely available to the research community. NCI will only accept applications that are highly relevant to cancer research.

Submit by March 1, 2019 to SWOG/Hope Foundation

    Title: Career Engagement Award – A Program for Mid-Career Investigators
    Award: $100,000
    Link: https://thehopefoundation.org/research-funding/juried-programs/career-engagement/
    2-year fellowships of $50,000/year are provided as salary support ensuring that investigators’ time is protected for research in the clinic or laboratory. SWOG Member Institutions may nominate multiple candidates, as appropriate.

Submit by March 4, 2019 to NIH

    Title: Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed project (standard).
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-093.html
    NCI encourages submission of applications designed to study development, testing and implementation of multi-level digital health technology interventions aimed at improving cancer prevention and control along any aspect of the cancer control continuum to reduce cancer health disparities and promote health equity.

Submit by July 1, 2019 to SWOG/Hope Foundation

    Title: Impact Award 2019
    Award: $250,000
    Link: https://thehopefoundation.org/research-funding/juried-programs/swog-hope-foundation-impact-award/
    Encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects. The work proposed should use resources from completed SWOG trials or be directly translatable to clinical trials in SWOG and the NCTN in the foreseeable future. Funding for smaller feasibility projects that are critical to the conduct of future SWOG trials are also encouraged.

Submit by January 7, 2019 to National Institutes of Health (NIH)

    Title: Early-life Factors and Cancer Development Later in Life (R21 Clinical Trial Not Allowed)
    Award: $275,000
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-18-532.html
    Research toward a better mechanistic understanding of how early-life events and exposures contribute to the etiology of cancer later in life will allow for the development of effective interventions during pregnancy or early life that may have a profound impact on cancer prevention.

    Title: Early-life Factors and Cancer Development Later in Life (R03 Clinical Trial Not Allowed)
    Award: $100,000
    Link: https://grants.nih.gov/grants/guide/pa-files/PA-18-531.html
    Research toward a better mechanistic understanding of how early-life events and exposures contribute to the etiology of cancer later in life will allow for the development of effective interventions during pregnancy or early life that may have a profound impact on cancer prevention.

Submit by December 15, 2018 to Transdisciplinary (TD) Research on Energetics and Cancer (TREC)

    Title: 3rd Annual Training Workshops for Early Investigators
    Award: Costs of the workshop, excluding ground transportation
    Link: https://publichealth.yale.edu/trecrep/
    Intent to apply due 12/15; full application due 1/14. This 5-day, in residence Workshop is offered annually and places emphasis on developing and applying TD competencies focused on energetics (i.e., obesity, diet and exercise) and cancer.

Submit by January 7, 2019 to Sarcoma Alliance for Research Through Collaboration (SARC)

    Title: Career Development Award
    Award: $100,000
    Link: https://sarctrials.org/funding-opportunities#careerdev
    Initiated to support the ideas and work of investigators that complement the depth of sarcoma translational research and to help ensure the continual renewal of high-quality scientific endeavors in the SARC Sarcoma SPORE

Submit by February 16, 2019 to NIH

    Title: Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
    Award: $200,000
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-069.html
    Small research projects that involve analyses of genomic and phenotypic datasets that are part of the Kids First Data Resource or that could be added to the Data Resource.

Submit by December 15 to the International Association for the Study of Lung Cancer (IASLC):

    Title:Lung Cancer Fellowship and Young Investigators Awards
    Award: u$50,000
    Link: https://www.iaslc.org/fellowship/announcements
    Funds provided for young investigators who wish to pursue a career in lung cancer diagnosis, treatment, or laboratory research as well as other aspects of the study of lung tumors. Must be an IASLC member.

Limited Submission: Submit by December 17, 2018 to the Mary Kay Foundation:

Submit by December 31, 2018 to the Elsa U. Pardee Foundation:

    Title: Cancer Research Grants
    Award:: Unspecified
    Link: https://pardeefoundation.org/how-to-apply/
    The Foundation particularly encourages grant applications for a one-year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers.

Submit by January 4, 2019 to the NIH:

    Title: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)
    Award: up to $5,500,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-010.html
    Purpose: to address primary cancer prevention; but applications directed toward immunoprevention of progression of premalignant lesions (e.g., adenomas of the colon as seen in Familial Polyposis or progression of benign neurofibromas to malignant tumors) will be considered.

Submit by January 11, 2019 to the NIH:

    Title: Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS, Second Wave) (UG3/UH3 Clinical Trial Required))
    Award:: up to $3,700,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-018.html
    Purpose: to promote research in colorectal cancer (CRC) screening, follow-up, and referral-to-care in regions of the United States (U.S.) where screening rates are below national standards.

    Title: Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed))
    Award: up to $4,500,000br /> Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-013.html
    Purpose: for i3 Centers to be supported by this FOA is to employ immuno-engineering principles to design more durable, accessible, and less toxic immunoprevention and immunotherapy strategies.

Limited Submission - Submit by January 16, 2019 to the Damon Runyon Cancer Research Foundation

Submit by February 8, 2019 to the NIH:

    Title: Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)
    Award: up to $2,500,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-014.html
    Purpose: to address primary cancer prevention; but applications directed toward immunoprevention of progression of premalignant lesions (e.g., adenomas of the colon as seen in Familial Polyposis or progression of benign neurofibromas to malignant tumors) will be considered.

    Title: Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)
    Award: up to $2,000,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-015.html
    Purpose: organ site-specific Cancer Immunotherapy Research Projects; to conduct systematic and comprehensive investigation of host immune cell-tumor cell interactions across multiple human cancers, including both “hot” and “cold” cancers, to define how tumor cells recruit and alter immune cell function to generate immunosuppressive tumor-promoting environments, and identify how to reprogram immune cells or the cancer microenvironment to promote anti-tumor immune responses.

Submit by February 11, 2019 to the NIH

    Title: Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3 Clinical Trials Not Allowed)
    Award: up to $2,500,000
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-012.html
    These Phased Award Projects are expected to focus on cancers that occur in specific organ sites in high-risk sub-populations. The goal is to accelerate the discovery of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.

External funding opportunities are broken down by the month in which they are due


View All | Close

December

Deadline: December 11, 2018

Deadline: December 15, 2018

    Sponsor: Transdisciplinary (TD) Research on Energetics and Cancer (TREC)
    Title: 3rd Annual Training Workshops for Early Investigators
    Award: Costs of the workshop, excluding ground transportation
    Link: https://publichealth.yale.edu/trecrep/

Deadline: December 17, 2018

Deadline: December 18, 2018

Deadline: December 31, 2018

January, 2019

Deadline: January 4, 2019

Deadline: January 5, 2019

    Sponsor: NIH
    Title: NIH: Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) (PA-18-945)
    Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. (standard)
    Contact: https://grants.nih.gov/grants/guide/pa-files/PA-18-945.html

Deadline: January 7, 2019

Deadline: January 9, 2019

Deadline: January 11, 2019

Deadline: January 15, 2019

Deadline: January 16, 2019

Deadline: January 17, 2019

    Sponsor: American Association for Cancer Research-AstraZeneca Ovarian Cancer Research Fellowship
    Title: Ovarian Cancer Research Fellowships
    Amount: $120,000
    Link https://www.aacr.org/Funding/Pages/Funding-Detail.aspx?ItemID=58

Deadline: January 24 2019

February, 2019

Deadline: February 5, 2019

Deadline: February 8, 2019

Deadline: February 11, 2019

Deadline February 16, 2019

Deadline: February 22, 2019

March, 2019

March 1, 2019

March 4, 2019

    Sponsor: National Institutes of Health (NIH)
    Title: Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed) (PAR-19-018)
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed project. (standard)
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-018.html

    Sponsor: NIH
    Title: Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed) (PAR-19-019)
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed project. (standard)
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-019.html

    Sponsor: NIH
    Title: Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)
    Award: Application budgets are not limited but need to reflect the actual needs of the proposed project (standard).
    Link: https://grants.nih.gov/grants/guide/pa-files/PAR-19-093.html

April, 2019

There are none at this time.

May, 2019

May 25, 2019

    Sponsor: National Institutes of Health (NIH)
    Title: Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32] (RFA-OD-19-011)
    Award: Application budgets are not limited, but each institutional training program will be asked to appoint up to 5 trainees annually. Budgets need to reflect the actual needs of the proposed project.
    Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-011.html

June, 2019

None at this time.

July, 2019

Submit by July 1, 2019

August, 2019

None at this time.

September, 2019

None at this time.

October, 2019

None at this time.

November, 2019

None at this time.


Additional Funding Sources:

back to top